← Open Payments lookup

SHERRYL LUVIS: Open Payments

NPI 1275812851 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,076 in 74 payments from 13 companies in 2025. Trend: 2023 $949 · 2024 $906 · 2025 $1,076

Food & beverage: $1,076
CompanyPaymentsAmount
ABBVIE INC.25$289
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)14$213
Novo Nordisk Inc10$139
Otsuka America Pharmaceutical, Inc.6$137
AstraZeneca Pharmaceuticals LP4$75
Lilly USA, LLC4$75
Phathom Pharmaceuticals, Inc.5$48
ALK-Abello, Inc1$19
Lundbeck LLC1$18
Teva Pharmaceuticals USA, Inc.1$17

Products named: VRAYLAR, CAPLYTA, REXULTI, Wegovy, AIRSUPRA, MOUNJARO, VOQUEZNA, Ozempic.

Industry payments across CO — which companies pay providers there.